Market Closed - Euronext Paris 11:39:07 2024-05-28 am EDT 5-day change 1st Jan Change
88.58 EUR -1.42% Intraday chart for Sanofi -1.58% -1.31%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
EU okays $1.5 bln state funded joint hydrogen project, $1.1 bln joint healthcare project RE
Sanofi Gets US FDA’s Priority Review for Expanded Use of Blood Cancer Drug Sarclisa MT
Sanofi: FDA grants priority review in myeloma CF
Sarclisa Accepts for FDA Priority Review for the Treatment of Transplant-Ineligible Newly Diagnosed Multiple Myeloma CI
US, European nations consider vaccinating workers exposed to bird flu RE
Inhibrx Shareholders Approve Sale of INBRX-101 Assets to Sanofi MT
Novavax awaits FDA decision on whether its next COVID shot can be offered in US RE
Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading MT
CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer MT
Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million RE
Sanofi Partners with Microsoft-Backed OpenAI, Formation Bio to Develop Drugs with AI MT
Sanofi: cooperation with Formation Bio and OpenAI CF
Sanofi Teams Up with Formation Bio, OpenAI for Drug Development AI Software MT
France's Sanofi Partners With OpenAI to Accelerate Drug Development DJ
Sanofi partners with OpenAI, Formation Bio on AI-driven drug development RE
Press Release Sanofi, Formation Bio And Openai Announce First-In-Class Ai Collaboration RE
Sanofi: positive data for Dupixent in COPD CF
Regeneron, Sanofi Disclose Positive Results for Lung Disease Treatment Candidate MT
Shah Capital ends campaign against Novavax board after Sanofi deal RE
Shah Capital withdraws campaign against Novavax directors after Sanofi deal RE
Transcript : Sanofi Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM
Global markets live: Apple, Sony, Vodafone, Booking, Walmart... Our Logo
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading MT
Sanofi India's Net Profit Slides in Q1 MT
Novavax Shares Pop Another 50% Following Sanofi Deal DJ
Chart Sanofi
More charts
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Mean consensus
Number of Analysts
Last Close Price
88.58 EUR
Average target price
108.2 EUR
Spread / Average Target
  1. Stock Market
  2. Equities
  3. SAN Stock
  4. News Sanofi
  5. Sanofi Launches Rabies Vaccine in the UK